VYM Fund discussed as income source in retirement portfolio strategy
1 report, 1 independent
Updated Thu 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
VYM, a Vanguard fund, is mentioned in the context of retirement strategies designed to shift a portfolio from accumulation to income. The fund is noted for providing a diversified dividend core for retirees.
From aol.com
Why it matters
The fund is presented as a tool for generating income for retirees. Vanguard holds shares of Johnson & Johnson and AbbVie as part of its investment portfolio.
Exchange-Traded Funds like VYM are known for their yield, sector tilts, and specific corporate holdings.
From aol.com
Who's involved
- Johnson & JohnsonJohnson & Johnson is held by Vanguard as part of its investment portfolio.
- AbbVieAbbVie's shares are held in Vanguard's funds, such as VYM.
- VanguardVanguard manages the VYM fund, which holds shares of Johnson & Johnson and AbbVie.
Keep exploring
The entities involved
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
JPMorgan Chase
American multinational banking and financial services holding company
-
AbbVie
pharmaceutical company
-
Vanguard
manufacturer of photo, video, camera accessories
Related events
- Johnson & Johnson, BDX, and Universal Health Realty Income Trust were identified as attractive dividend-paying healthcare stocks.
- AbbVie and Johnson & Johnson are top exposures in the VYM ETF, which itself holds Microsoft.
- Johnson & Johnson and Realty Income are noted for competing dividend investment vehicles.
- Procter & Gamble, Johnson & Johnson, Coca-Cola, and Verizon are discussed as income-generating companies referenced in dividend investment strategies.